Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

NEWS ABOUT >

Biotechnology

Clean Rooms

Clinical Trials

Consultants

Digitalization

Drug Discovery & Development

Engineering

Global Pharma

Industrial talks

Ingredients

Lab Equipment

Logistics & Distribution

Manufacturing

Market

Outsourcing

Packaging

Quality / GMP

Regulation

Safety

Last edition

All magazines
Subscribe to our magazine

News about "Stablepharma"

World-First Fridge-Free Tetanus-Diphtheria Vaccine Trial Shows Promising Results

Stablepharma’s SPVX02 remains potent for up to two years at temperatures of up to 30°C, potentially reducing cold-chain dependence, vaccine wastage and barriers to immunisation in remote regions.

Stablepharma | 10/08/2026 | By News Bureau

UK Health Security Agency Supports Development of Fridge-Free Tetanus-Diphtheria Vaccine SPVX02 After Successful Phase I Trial

UK Health Security Agency and Stablepharma report positive Phase I results for SPVX02, a fridge-free Tetanus and Diphtheria vaccine stable at 30°C for 24 months.

Stablepharma | 17/03/2026 | By News Bureau | 111

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members